Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
5126
Autolus Therapeutics
AUTL
$572M
| $2.44M | ﹤0.01% |
1,142,605
-1,011,052
| -47% | -$3M |
|
|
SLCA
5127
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.44M | ﹤0.01% |
223,100
+38,300
| +21% | +$487K |
|
5128
CALL
Jack Henry & Associates
JKHY
$10.9B
| $2.44M | ﹤0.01% |
13,400
-2,300
| -15% | -$451K |
|
|
AKRO
5129
CALL
DELISTED
Akero Therapeutics
AKRO
| $2.44M | ﹤0.01% |
+71,700
| New | +$1.1M |
|
5130
Fidelity MSCI Materials Index ETF
FMAT
$614M
| $2.44M | ﹤0.01% |
+64,232
| New | +$2.71M |
|
5131
Genworth Financial
GNW
$3.84B
| $2.44M | ﹤0.01% |
697,010
+269,100
| +63% | +$1.09M |
|
5132
CALL
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $2.44M | ﹤0.01% |
70,200
+22,200
| +46% | +$867K |
|
5133
CALL
DigitalBridge
DBRG
$2.94B
| $2.44M | ﹤0.01% |
195,000
+162,100
| +493% | +$3.12M |
|
5134
PUT
Boston Properties
BXP
$10.9B
| $2.44M | ﹤0.01% |
32,500
-32,100
| -50% | -$2.73M |
|
5135
Beazer Homes USA
BZH
$872M
| $2.44M | ﹤0.01% |
252,091
+99,894
| +66% | +$1.37M |
|
5136
CALL
Cogent Communications
CCOI
$579M
| $2.44M | ﹤0.01% |
46,700
-5,300
| -10% | -$306K |
|
5137
iShares US Small Cap Equity Factor ETF
SMLF
$4.33B
| $2.44M | ﹤0.01% |
+54,428
| New | +$2.69M |
|
|
JOYY
5138
PUT
JOYY Inc
JOYY
$3.68B
| $2.44M | ﹤0.01% |
93,700
+4,600
| +5% | +$126K |
|
|
UDMY
5139
DELISTED
Udemy
UDMY
| $2.44M | ﹤0.01% |
201,472
-41,762
| -17% | -$557K |
|
|
VERV
5140
DELISTED
Verve Therapeutics
VERV
| $2.43M | ﹤0.01% |
70,830
-1,010,725
| -93% | -$32.3M |
|
|
SRNE
5141
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.43M | ﹤0.01% |
1,549,054
+884,632
| +133% | +$2.01M |
|
5142
CALL
Jefferies Financial Group
JEF
$12.7B
| $2.43M | ﹤0.01% |
86,190
+4,079
| +5% | +$123K |
|
5143
CALL
Sensata Technologies
ST
$6.73B
| $2.43M | ﹤0.01% |
65,200
+54,700
| +521% | +$2.29M |
|
5144
PUT
ProShares UltraPro Russell2000
URTY
$368M
| $2.43M | ﹤0.01% |
71,000
+12,500
| +21% | +$597K |
|
5145
PUT
Boot Barn
BOOT
$4.95B
| $2.43M | ﹤0.01% |
41,500
-5,300
| -11% | -$355K |
|
5146
CALL
Crinetics Pharmaceuticals
CRNX
$8.99B
| $2.43M | ﹤0.01% |
123,500
-10,100
| -8% | -$206K |
|
5147
PUT
Eastern Bankshares
EBC
$5.4B
| $2.43M | ﹤0.01% |
123,500
+26,100
| +27% | +$522K |
|
5148
CALL
Acadia Pharmaceuticals
ACAD
$4.87B
| $2.42M | ﹤0.01% |
148,100
-309,100
| -68% | -$5.01M |
|
|
PENG
5149
PUT
Penguin Solutions Inc
PENG
$3.27B
| $2.42M | ﹤0.01% |
152,700
-23,500
| -13% | -$428K |
|
5150
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $2.42M | ﹤0.01% |
41,607
+10,325
| +33% | +$658K |
|
Similar funds
Ken Griffin's Q3 2022 Portfolio in Review
As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
- Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.